Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study

Table 1

Clinicopathological characteristics of PTC cases.

(a)

	Mean	±SD (range)
Age	43.62	12.77 (18.00–86.00)
Tumor size (cm)	3.78	1.27 (1.00–7.00)

(b)

		Number	%
Age group	<55	122	51.3%
	≥55	116	48.7%
Gender	Male	48	20.2%
	Female	190	79.8%
Lymph node involvement at presentation	N0	164	68.9%
	N1	74	31.1%
Lymphovascular invasion	Negative	192	80.7%
	Positive	46	19.3%
Capsular invasion	Negative	127	53.4%
	Positive	111	46.6%
PTC variants	Classic	172	72.3%
	Follicular	51	21.4%
	Other	15	6.3%
Extrathyroid extension	Negative	207	87.0%
	Positive	31	13.0%
Stage	I	189	79.4%
	II	38	16.0%
	III	11	4.6%
Tumor size (cm)	≤4	114	47.9%
	>4	124	52.1%
Distant metastasis	Negative	219	92.0%
	Positive	19	8.0%
Local recurrence	Negative	205	86.1%
	Positive	33	13.9%
Outcome	Dead	16	6.7%
	Alive	222	93.3%